U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Description
Curator's Comment: description was created based on several sources, including: https://www.drugs.com/npc/gamma-oryzanol.html http://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm275973.pdf

Gamma-oryzanol is a naturally occurring component in rice bran and rice germ, which consists of a mixture of ferulic acid esters of sterols and triterpene alcohols. The mechanism of action of gamma-oryzanol is believed to be involved in the metabolism of catecholamine in the hypothalamus. The antioxidant effect of gamma-oryzanol was well documented and excellent in inhibiting lipid peroxidation. Isolation, extraction, and purification of gamma oryzanol were first reported in the mid-1950s. It has been sold in Japan as a medicine since 1962, first to treat anxiety and later in menopause. Gamma oryzanol and rice bran oil therapy have been used to manage elevated cholesterol and triglyceride levels since the late 1980s. No human clinical studies reported adverse effects of rice bran or its fiber fraction.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
ORURU

Approved Use

It is usually used to improve various symptoms associated with climacteric disturbance

Launch Date

3.22617606E11
Primary
ORURU

Approved Use

It is usually used to treat hyperlipidemia.

Launch Date

3.22617606E11
Palliative
ORURU

Approved Use

It is usually used to improve various symptoms associated with irritable bowel syndrome

Launch Date

3.22617606E11
PubMed

PubMed

TitleDatePubMed
Effects of combined dietary supplementation on oxidative and inflammatory status in dyslipidemic subjects.
2006 Mar
Upregulation of genes related to bone formation by γ-amino butyric acid and γ-oryzanol in germinated brown rice is via the activation of GABAB-receptors and reduction of serum IL-6 in rats.
2013
γ-Oryzanol protects against acute cadmium-induced oxidative damage in mice testes.
2013 May
Patents

Sample Use Guides

The dosage against hyperlipemia is 300 mg per day for adult, and against menopausal symptoms and mild anxiety is 10 to 50 mg per day; 6 mg once a day for 3 months for anti-inflammatory effect on skin
Route of Administration: Oral
Gamma-oryzanol is able to inhibit lipid soluble organic radicals at oncentration of 50–100M.
Substance Class Mixture
Created
by admin
on Sat Dec 16 08:45:54 UTC 2023
Edited
by admin
on Sat Dec 16 08:45:54 UTC 2023
Record UNII
SST9XCL51M
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GAMMA ORYZANOL
JAN   VANDF  
Preferred Name English
ORYZANOL
INCI   MART.   WHO-DD  
INCI  
Official Name English
THIAMINOGEN
Brand Name English
GAMMARIZA
Common Name English
ORYVITA
Brand Name English
CACLATE
Brand Name English
GAMMA-ORYZANOL [USP-RS]
Common Name English
.GAMMA.-ORYZANOL
MI  
Common Name English
GAMMA-OZ
Brand Name English
GAMMA ORYZANOL [JAN]
Common Name English
.GAMMA.-ORYZANOL [MI]
Common Name English
HI-Z
Brand Name English
Oryzanol [WHO-DD]
Common Name English
ORYZAAL
Brand Name English
GAMMAJUST 50
Brand Name English
OLIVER
Brand Name English
ORYZANOL [MART.]
Common Name English
ORYZANOL, .GAMMA.-
Common Name English
ORYZANOL [INCI]
Common Name English
GAMMA-ORYZANOL
Common Name English
GAMMATSUL
Brand Name English
MASPIRON
Brand Name English
GUNTRIN
Brand Name English
GAMMA ORYZANOL [VANDF]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29701
Created by admin on Sat Dec 16 08:45:54 UTC 2023 , Edited by admin on Sat Dec 16 08:45:54 UTC 2023
DSLD 1419 (Number of products:112)
Created by admin on Sat Dec 16 08:45:54 UTC 2023 , Edited by admin on Sat Dec 16 08:45:54 UTC 2023
Code System Code Type Description
MESH
C013172
Created by admin on Sat Dec 16 08:45:54 UTC 2023 , Edited by admin on Sat Dec 16 08:45:54 UTC 2023
PRIMARY
WIKIPEDIA
γ-Oryzanol
Created by admin on Sat Dec 16 08:45:54 UTC 2023 , Edited by admin on Sat Dec 16 08:45:54 UTC 2023
PRIMARY
FDA UNII
SST9XCL51M
Created by admin on Sat Dec 16 08:45:54 UTC 2023 , Edited by admin on Sat Dec 16 08:45:54 UTC 2023
PRIMARY
GRAS Notification (GRN No.)
800
Created by admin on Sat Dec 16 08:45:54 UTC 2023 , Edited by admin on Sat Dec 16 08:45:54 UTC 2023
PRIMARY
MERCK INDEX
m8253
Created by admin on Sat Dec 16 08:45:54 UTC 2023 , Edited by admin on Sat Dec 16 08:45:54 UTC 2023
PRIMARY Merck Index
RS_ITEM_NUM
1479202
Created by admin on Sat Dec 16 08:45:54 UTC 2023 , Edited by admin on Sat Dec 16 08:45:54 UTC 2023
PRIMARY
EVMPD
SUB14720MIG
Created by admin on Sat Dec 16 08:45:54 UTC 2023 , Edited by admin on Sat Dec 16 08:45:54 UTC 2023
PRIMARY
DAILYMED
SST9XCL51M
Created by admin on Sat Dec 16 08:45:54 UTC 2023 , Edited by admin on Sat Dec 16 08:45:54 UTC 2023
PRIMARY
RXCUI
25608
Created by admin on Sat Dec 16 08:45:54 UTC 2023 , Edited by admin on Sat Dec 16 08:45:54 UTC 2023
PRIMARY RxNorm
NCI_THESAURUS
C65799
Created by admin on Sat Dec 16 08:45:54 UTC 2023 , Edited by admin on Sat Dec 16 08:45:54 UTC 2023
PRIMARY
ChEMBL
CHEMBL2106452
Created by admin on Sat Dec 16 08:45:54 UTC 2023 , Edited by admin on Sat Dec 16 08:45:54 UTC 2023
PRIMARY
EVMPD
SUB91960
Created by admin on Sat Dec 16 08:45:54 UTC 2023 , Edited by admin on Sat Dec 16 08:45:54 UTC 2023
PRIMARY
EPA CompTox
DTXSID6021084
Created by admin on Sat Dec 16 08:45:54 UTC 2023 , Edited by admin on Sat Dec 16 08:45:54 UTC 2023
PRIMARY
CAS
11042-64-1
Created by admin on Sat Dec 16 08:45:54 UTC 2023 , Edited by admin on Sat Dec 16 08:45:54 UTC 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY
Definition References